Correlation Between A SPAC and Drugs Made

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both A SPAC and Drugs Made at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining A SPAC and Drugs Made into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between A SPAC III and Drugs Made In, you can compare the effects of market volatilities on A SPAC and Drugs Made and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in A SPAC with a short position of Drugs Made. Check out your portfolio center. Please also check ongoing floating volatility patterns of A SPAC and Drugs Made.

Diversification Opportunities for A SPAC and Drugs Made

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between ASPCU and Drugs is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding A SPAC III and Drugs Made In in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Drugs Made In and A SPAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on A SPAC III are associated (or correlated) with Drugs Made. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Drugs Made In has no effect on the direction of A SPAC i.e., A SPAC and Drugs Made go up and down completely randomly.

Pair Corralation between A SPAC and Drugs Made

Assuming the 90 days horizon A SPAC III is expected to under-perform the Drugs Made. In addition to that, A SPAC is 5.81 times more volatile than Drugs Made In. It trades about 0.0 of its total potential returns per unit of risk. Drugs Made In is currently generating about 0.04 per unit of volatility. If you would invest  1,027  in Drugs Made In on July 26, 2025 and sell it today you would earn a total of  5.00  from holding Drugs Made In or generate 0.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

A SPAC III  vs.  Drugs Made In

 Performance 
       Timeline  
A SPAC III 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days A SPAC III has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, A SPAC is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Drugs Made In 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Drugs Made In are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Drugs Made is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

A SPAC and Drugs Made Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with A SPAC and Drugs Made

The main advantage of trading using opposite A SPAC and Drugs Made positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if A SPAC position performs unexpectedly, Drugs Made can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Drugs Made will offset losses from the drop in Drugs Made's long position.
The idea behind A SPAC III and Drugs Made In pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals